Table 1.

Patient characteristics of the treatment group and control groupsa

ParameterTreatment Group (%)Literature Control Group (%)P ValuebUSRDS Control Group (%)P Valuec
aUSRDS, US Renal Data System; NS, not significant; Ccr, creatine clearance; RRT, renal replacement therapy; NA, data not available.
bComparing the literature control group with the treatment group.
cComparing the USRDS control group with the treatment group.
No. patients241242
Race
white23 (96%)10 (83%)34 (81%)
black1 (4%)2 (17%)NS5 (12%)NS
other003 (7%)
Gender
female7 (30%)5 (42%)NS14 (33%)NS
male17 (70%)7 (58%)28 (67%)
Disease
polycystic kidney1 (4%)08 (20%)
urologic causes22 (92%)9 (75%)NS12 (30%)0.001
other causes1 (4%)3 (25%)21 (50%)
Ccr
<10 ml/min per 1.73 m210 (42%)1 (8%)
10-50 ml/min per 1.73 m212 (50%)8 (67%)<0.05NA
>50 ml/min per 1.73 m22 (8%)3 (25%)
RRT
none17 (71%)0
dialysis7 (29%)NA35 (83%)0.001
transplant07 (17%)